Buried In Plain Sight
Toward the end of an article about drug "supply problems", is this little gem:
___________________________________________
Last week, the Danish drugmaker also said it had more than doubled its supply of lower-dose versions of its weight loss injection Wegovy in January compared to previous months. Supply shortages forced Novo Nordisk to restrict the availability of those lower doses in the U.S. since May.
But why are those lower doses important? It’s because people are supposed to start Wegovy at a low dose and gradually increase the size over time to mitigate side effects such as nausea. So, more of those low “starter” doses means more new patients can begin treatment with Wegovy.
___________________________________________
Nausea is the body's way of saying, “Hey, stop it! This stuff is poison!”.
PharmaDoctors cavalierly claim, “Oh that's normal, it's just a little “side effect”, it'll go away after your body gets used to it”. In other words, the drug kills off the warning signs, your body's attempt to get you to WTFU.
The CNBC article thus points out one of the common traits of FDA-approved drugs, and “street drugs”: Both will kill you. And after taking either for a while, the claimed “need” increases, while the harm—often irreparable unless you have access to a genuine healer, or access to the means to heal—brings upon an early and painful death.
At the same time, the drug dealers' profits increase. “Healthy Returns” indeed, on drug company investments. Not so healthy for the people whose food and water particularly have been corrupted to promote that weight gain.
Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes